Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangjingqiyuan is a traditional Chinese medicine (TCM) combination product, primarily available in capsule or oral liquid form, developed and manufactured by Ningxia Qiyuan Pharmaceutical. It is formulated with a blend of herbal extracts, typically including **Huangjing** (*Polygonatum sibiricum*), **Gouqi** (*Lycium barbarum*), **Ginseng** (*Panax ginseng*), and **Epimedium** (*Epimedium brevicornu*). The product is marketed in China as a registered "Health Food" (Blue Hat), intended to tonify the kidney, nourish the spleen, moisten the lungs, and replenish vital essence (Qi). It is commonly used to relieve physical fatigue, improve immune function, and address symptoms associated with "kidney deficiency" or general exhaustion. While not a prescription pharmaceutical in the Western sense, it is widely utilized in clinical and sub-health management contexts within the Chinese market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huangjingqiyuan.